2024
DOI: 10.1097/mou.0000000000001169
|View full text |Cite
|
Sign up to set email alerts
|

Metastasis-directed therapy in oligometastatic prostate cancer

Marcin Miszczyk,
Timo Soeterik,
Giancarlo Marra
et al.

Abstract: Purpose of review To summarize the recent findings on the subject of metastasis-directed therapy (MDT) in the treatment of oligometastatic prostate cancer (omPCa). Recent findings Evidence from two randomized clinical trials (RCTs) and a meta-analysis show favorable toxicity profiles, and the potential to delay androgen-deprivation therapy (ADT) for up to two years in nearly half of patients with metachronous hormone-sensitive omPCa. Another RCT showed … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 26 publications
0
0
0
Order By: Relevance